(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIDA PHARMACAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VIDA PHARMACAL

ST13

US500000090040233

Class

42, 44

Filing

90040233

Registration

7391955

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

05/21/2024

Trademark type

Combined

Nice classes

42, 44

Filing date

07/07/2020

Registration date

05/21/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/21/2024

Last transaction

05/21/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/14/2023

First use in commerce

11/14/2023

Drawing code

3

Owner type

03

Owner location

Spring Branch, TX

Examiner

CROWLEY, SEAN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a heart in orange, dark orange, and yellow and the stylized wording "VIDA PHARMACAL" in gray. The color white represents background and is not part of the mark.

Holders and representatives

Holders

Vida Pharmacal, Ltd.

Representatives

B. Aaron Schulman STITES & HARBISON

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and medical research services; providing medical and scientific research information in the field of pharmaceuticals; research and development of new medical products and treatments for Chagas disease in humans and animals

Class 44

Pharmaceutical advice; pharmaceutical servicesproviding pharmaceutical advice and consultation and dispensing drugs to patients with Chagas disease; consultancy and medical information services relating to Chagas disease

Publications

History of USPTO decisions and trademark events.

43 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/21/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/21/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/18/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/18/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/01/2024

IUAF

USE AMENDMENT FILED

03/29/2024

EISU

TEAS STATEMENT OF USE RECEIVED

03/29/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/11/2023

EX5G

SOU EXTENSION 5 GRANTED

10/10/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/10/2023

EXT5

SOU EXTENSION 5 FILED

09/29/2023

EEXT

SOU TEAS EXTENSION RECEIVED

09/29/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/01/2023

EX4G

SOU EXTENSION 4 GRANTED

03/30/2023

EXT4

SOU EXTENSION 4 FILED

03/30/2023

EEXT

SOU TEAS EXTENSION RECEIVED

03/30/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/29/2022

EX3G

SOU EXTENSION 3 GRANTED

09/27/2022

EXT3

SOU EXTENSION 3 FILED

09/27/2022

EEXT

SOU TEAS EXTENSION RECEIVED

09/27/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/17/2022

EX2G

SOU EXTENSION 2 GRANTED

03/15/2022

EXT2

SOU EXTENSION 2 FILED

03/15/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/15/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/30/2021

EX1G

SOU EXTENSION 1 GRANTED

09/28/2021

EXT1

SOU EXTENSION 1 FILED

09/28/2021

EEXT

SOU TEAS EXTENSION RECEIVED

09/28/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/30/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/02/2021

PUBO

PUBLISHED FOR OPPOSITION

02/02/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/13/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/23/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/14/2020

GNRT

NON-FINAL ACTION E-MAILED

10/14/2020

CNRT

NON-FINAL ACTION WRITTEN

10/14/2020

DOCK

ASSIGNED TO EXAMINER

10/14/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/05/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/04/2020

NWAP

NEW APPLICATION ENTERED

07/10/2020

Continuous trademark protection

Get notified about every new filing that threatens VIDA PHARMACAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.